The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study have?
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study has 130 citations in the OpenAlex counts ScholarIQ stores.
When was The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study published?
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study has 2020 year in the ScholarIQ index.
What is the open-access status of The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study?
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study has gold oa status in the ScholarIQ index.
What is the DOI of The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study?
The DOI for The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study is on the source record.
What is the PMID of The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study?
The PMID for The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study is on the source record.
What is the OpenAlex record for The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study?
The OpenAlex for The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study is on the source record.